NR3C2 and prediabetes syndrome: Patients with prediabetes were less likely to receive calcium channel blockers, loop diuretics, and mineralocorticoid receptor antagonists compared to the T2DM2 group (p = 0.018, p = 0.003, and p = 0.001, respectively; Table 1).